These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20049592)

  • 1. Bilateral, symmetrical soft tissue calcifications in the face.
    Vazquez J; Rosenthal DI
    Skeletal Radiol; 2010 Apr; 39(4):387-9. PubMed ID: 20049592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammographic appearance of calcium hydroxylapatite (RadiesseTM) injected into the breast for nipple reconstruction.
    Holbrook A; Lee S; Soo MS
    Breast J; 2013; 19(1):104-13. PubMed ID: 23241079
    [No Abstract]   [Full Text] [Related]  

  • 3. How to make calcium hydroxylapatite injections safer.
    Aguilera SB; Tivoli YA; Seastrom SJ
    J Drugs Dermatol; 2014 Sep; 13(9):1015. PubMed ID: 25225999
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiological case of the month. Soft-tissue calcification caused by calcium gluconate extravasation.
    Packer JE; Naidech HJ; Young LW
    Am J Dis Child; 1984 May; 138(5):505-6. PubMed ID: 6711509
    [No Abstract]   [Full Text] [Related]  

  • 5. Foreign body reaction to calcium hydroxylapatite after lip augmentation.
    Sankar V; McGuff HS
    J Am Dent Assoc; 2007 Aug; 138(8):1093-6. PubMed ID: 17670876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation.
    Jansen DA; Graivier MH
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):22S-30S, discussion 31S-33S. PubMed ID: 16936541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulomatous deposition after calcium hydroxylapatite filler injection.
    Itamura K; House AE; Pokress H; Larian B; Azizzadeh B
    J Cosmet Dermatol; 2022 Dec; 21(12):7233-7234. PubMed ID: 36102420
    [No Abstract]   [Full Text] [Related]  

  • 8. Bilateral blindness after filler injection.
    Kim YJ; Choi KS
    Plast Reconstr Surg; 2013 Feb; 131(2):298e-299e. PubMed ID: 23358039
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel solution for superficially placed calcium hydroxylapatite (Radiesse) in the inferior eyelid.
    Vrcek IM; Malouf P; Gilliland GD
    Orbit; 2012 Dec; 31(6):431-2. PubMed ID: 22731869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds.
    Carruthers A; Liebeskind M; Carruthers J; Forster BB
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S78-84. PubMed ID: 18547186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium hydroxylapatite facial filler (Radiesse): indications, technique, and results.
    Jacovella PF
    Clin Plast Surg; 2006 Oct; 33(4):511-23. PubMed ID: 17085220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting results with hydroxylapatite (Radiesse) facial filler.
    Jacovella PF; Peiretti CB; Cunille D; Salzamendi M; Schechtel SA
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):15S-21S. PubMed ID: 16936540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eyelid mass secondary to injection of calcium hydroxylapatite facial filler.
    Lee MJ; Sung MS; Kim NJ; Choung HK; Khwarg SI
    Ophthalmic Plast Reconstr Surg; 2008; 24(5):421-3. PubMed ID: 18806674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability.
    Silvers SL; Eviatar JA; Echavez MI; Pappas AL
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):34S-45S. PubMed ID: 16936543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual soft tissue radiopacity--radiographic appearance of a dermal filler.
    Valiyaparambil J; Rengasamy K; Mallya SM
    Br Dent J; 2009 Sep; 207(5):211-2. PubMed ID: 19749712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PET-CT Radiological Appearance of Facial Cosmetic Injections: A Pitfall in the Evaluation of the Oncological Patient.
    Davidson T; Druyan A; Goshen E; Lidar M
    Isr Med Assoc J; 2017 Nov; 19(11):679-681. PubMed ID: 29185280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications from Nasolabial Fold Injection of Calcium Hydroxylapatite for Facial Soft-Tissue Augmentation: A Systematic Review and Meta-Analysis.
    Shi XH; Zhou X; Zhang YM; Lei ZY; Liu T; Fan DL
    Aesthet Surg J; 2016 Jun; 36(6):712-7. PubMed ID: 27178901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications associated with injectable soft-tissue fillers: a 5-year retrospective review.
    Daines SM; Williams EF
    JAMA Facial Plast Surg; 2013 May; 15(3):226-31. PubMed ID: 23539246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium hydroxylapatite (Radiesse): safety, techniques and pain reduction.
    Busso M
    J Drugs Dermatol; 2009 Oct; 8(10 Suppl):s21-3. PubMed ID: 19891118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation.
    Tzikas TL
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S9-15. PubMed ID: 18547188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.